An interventional study of Date fruit and Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg in Pregnancy, sponsored by Bahria University. Active, not recruiting at 1 site in Pakistan. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-01-21.
Sponsored by Bahria University · Not applicable, Interventional, and Treatment
The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating morning sickness of pregnancy in pregnant females. The main question[s] it aims to answer [is/are]:
The goal of this randomized clinical trial is to evaluate role of date fruit in
The goal of this randomized clinical trial is to evaluate role of date fruit in alleviating vomiting due to morning sickness of pregnancy and in improving maternal hemoglobin in pregnant females. The main question[s] it aims to answer [are]:
A randomized Controlled trial to assess benefits of date fruit in morning sickness of pregnancy symptoms, inclusive of nausea and vomiting and to improve haemoglobin levels in pregnant females.
1,100 studies on the registry are indexed under Vomiting; 134 are open to participants now.
This study's planned enrollment of 40 is below the median of 107 across 935 interventional studies indexed under Vomiting.
Browse Vomiting studies →Bahria University is the lead sponsor of 35 studies on the registry; 10 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
3 Dates after breakfast
Other: Date fruit
Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg
Drug: Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg
Avoidance of high fat foods and enhanced intake of hydrating fruits and vegetables
Other: Diet
3 Dates after breakfast
Also known as: Date intake in morning
Doxylamine succinate 10 mg + Pyridoxine HCl 10 mg , One per day
Also known as: Antiemetic once per day
Avoidance of high in fat foods and enhanced intake of hydrating fruits and vegetables
Also known as: Diet as per advice
Hemoglobin
Complete blood picture (Laboratory diagnostic tests)
Time frame: 12 Weeks
Vomiting
PUQE-24 Score Unabbreviated scale title : The Pregnancy-Unique Quantification of Emesis and Nausea (PUQE-24) Minimum Value : 4-6 (Mild) Maximum Value : ≥13 (Severe) Higher Scores mean worst outcome
Time frame: 12 Weeks
Fatigue level
FAS Unabbreviated scale title: Fatigue Assessment Scale (FAS) Minimum Value : Less less than 22 Maximum Value : 35 or more indicates severe fatigue Higher Scores mean worst outcome
Time frame: 12 weeks
Dietary Recall
Direct compliance inquired via telephonic communication on regular basis
Time frame: 12 weeks
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bahria University